Reports

97 Results (Page 1 of 4)

North America Markets Research Reports

Pharmaceuticals

North America Oncology Drugs Market Analysis

This report presents a strategic analysis of the North America Oncology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the North America Oncology Drugs Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jan, 2024 | PRICE: $3999

Healthcare Services

North America Dental Care Market Analysis

North America Dental Care Market size is at around $17.94 Bn in 2022 and is projected to reach $27.32 Bn in 2030, exhibiting a CAGR of 5.4% during the forecast period. The economy of North America is one of the largest and most developed in the world with high purchasing parity and high demand for quality service. Despite strict regulation, major players like Aspen Dental, Pacific Dental Services, Heartland Dental, and Great Expressions Dental Centres continue to pioneer the dental service provision in the region. This report is segmented by treatment type, age group, clinical setup, and demography.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jan, 2024 | PRICE: $3999

Digital Health

North America Blockchain Technology in Healthcare Market Analysis

This report presents a strategic analysis of the North American blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the North American Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jan, 2024 | PRICE: $3999

Medical Devices

North America Biomaterials in Healthcare Market Analysis

This report presents a strategic analysis of the North America Biomaterials in Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about North American biomaterials in the Healthcare Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Healthcare Services

North America Bioinformatics Market Analysis

North America's Bioinformatics market is projected to grow from $7.68 Bn in 2022 to $23.97 Bn by 2030, registering a CAGR of 15.30% during the forecast period of 2022-30. The main factors driving the growth would be technological advancements, an increase in investment for research, strong healthcare infrastructure, and increasing demand for nucleic acid and molecular sequencing. The market is segmented by technology and by application. Some of the major players include Biovia, IBM Life Sciences, 3rd Millennium, Illumina, Agilent Technologies, and Affymetrix.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

North America Anemia Drugs Market Analysis

North America's Anemia drugs market was valued at $7.99 Bn in 2022 and is estimated to expand at a CAGR of 7.9% from 2022-30 and will reach $14.68 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Amgen, Pfizer, Amgen, Bayer AG, Biocon, and Bluebird Bio among others.

PUBLISHED: Mar, 2023 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

Pharmaceuticals

North America Advanced Therapy Medicinal Products (ATMPs) Market Analysis

This report presents a strategic analysis of the North American advanced Therapy Medicinal Products (ATMPs) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the North American advanced Therapy Medicinal Products (ATMPs) Market, offering unmatched value, accuracy, and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Dec, 2023 | PRICE: $3999

OTC & Nutraceuticals

North America Over The Counter (OTC) Pharmaceuticals Market Analysis

North America's over-the-counter (OTC) pharmaceuticals market size was valued at $78750 Mn in 2022 and is estimated to expand at a CAGR of 4.54% from 2022 to 2030 and will reach $98069.2 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Nov, 2023 | PRICE: $3999

Pharmaceuticals

North America Alzheimer’s Disease Drugs Market Analysis

North America Alzheimer’s disease drugs market was valued at $7.71 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.42% from 2022 to 2030 and will reach $13.67 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the development of drugs, the aging population. The market is segmented by drug classes and by distribution channels. Some key players in this market are Amgen, Eisai Co., Eli Lilly and Company, Roche and Johnson, and Johnson among others.

PUBLISHED: Mar, 2023 | FORMAT: PPT | LAST UPDATED: Oct, 2023 | PRICE: $3999

Pharmaceuticals

North America Alexipharmic Drugs Market Analysis

North America Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 3.70% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The North America Alexipharmic Drugs market will grow because there is a growing demand for safe and effective treatments for accidental poisoning. The key market players are Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., GlaxoSmithKline plc. and others.

PUBLISHED: Mar, 2023 | FORMAT: PPT | LAST UPDATED: Oct, 2023 | PRICE: $3999

Pharmaceuticals

North America Anti-Depressants Drugs Market Analysis

The North America Anti-Depressants drugs market size was valued at $8.22Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030 and will reach $12.05 Bn in 2030. The market is segmented by drug class, indication, route of administration, end-user, distribution channel, and geography. The North America Anti-Depressants drug market will grow because of the development of novel antidepressant drugs and the expansion of the product portfolio of pharmaceutical companies. The key market players are Eli Lilly and Company (USA), Pfizer Inc. (USA), Bristol-Myers Squibb (USA), and others.

PUBLISHED: Mar, 2023 | FORMAT: PPT | LAST UPDATED: Oct, 2023 | PRICE: $3999

Healthcare Services

North America Physiotherapy Market Analysis

North America's physiotherapy market size was valued at $26.6 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.85% from 2022 to 2030 and will reach $38.85 Bn in 2030. The North American physiotherapy market is expected due to an increase in the frequency of chronic illnesses, and growing public awareness of the benefits of physiotherapy. The market is segmented by Product Type Application Type and End User. The major players in the North American physiotherapy market are BTL, EMS Physio Ltd., Dynatronics Corporation, RICHMAR, and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Oct, 2023 | PRICE: $3999

Healthcare Services

North America Patient Engagement Solutions Market Analysis

North American patient engagement solutions market is projected to grow from $7.14 Bn in 2022 to $15.54 Bn by 2030, registering a CAGR of 10.2% during the forecast period of 2022-30. The main factors driving the growth would be the rising prevalence of chronic diseases, the requirement to lower costs of healthcare for greater accessibility, government laws supporting the healthcare system, and the concentration of key market players operating in the area. The market is segmented by component, delivery mode, application, therapeutic area, functionality, and end-user. Some of the major players include Allscripts, Cerner Corporation, McKesson, Athena Health, Telus Health, and WELL Health Technologies.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Oct, 2023 | PRICE: $3999

OTC & Nutraceuticals

North America Nutritional Supplements Market Analysis

This report presents a strategic analysis of the North America Nutritional Supplements Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the North America Nutritional Supplements Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Digital Health

North America Artificial Intelligence (AI) in Healthcare Market Analysis

This report presents a strategic analysis of North America Artificial Intelligence (AI) in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about North America Artificial Intelligence (AI) in the Healthcare Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Pharmaceuticals

North America Retail Pharmacy Market Analysis

This report presents a strategic analysis of the North America Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the North America Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jun, 2023 | PRICE: $3999

Pharmaceuticals

North America Diabetes Drugs Market Analysis

The North America diabetes drugs market size was valued at $4.69 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030 and will reach $6.99 Bn in 2030. The market is segmented by drug type, application, distribution channel, and geography. The North America diabetes drugs market will grow because of the growing focus on cardiovascular outcomes in the treatment of diabetes, as cardiovascular disease is a major complication of the disease. The key market players are Johnson & Johnson, Novo Nordisk, Novartis, Merck, Eli Lilly and Company, and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Mar, 2023 | PRICE: $3999

Pharmaceuticals

North America Breast Cancer Therapeutics Market Analysis

The North America breast cancer therapeutics market is expected to witness growth from $9.1 Bn in 2022 to $22.3 Bn in 2030 registering a CAGR of 11.9% for the year 2022-2030. The main market drivers for this growth are increasing awareness about breast cancer and post-menopausal obesity in women in North America. The market is segmented by therapy, by cancer type, and by distribution channel. AstraZeneca, Eisai, and Eli Lilly are some of the major market players in the North America breast cancer therapeutics market.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Pharmaceuticals

North America HIV Therapeutics Market Analysis

The North American HIV therapeutics market is expected to reach $7.81 Bn by 2030, up from $5.02 Bn in 2022, with a CAGR of 5.7% from 2022 to 2030. North American players such as Gilead Sciences, Merck & Co, Johnson & Johnson, and AbCellera Biologics dominate the North American HIV therapeutics market. The North American government policies, health infrastructure, lifestyle, and initiatives by international organizations to manage HIV infections propel the market. The North American HIV therapeutics market is divided into 5 segments type, product, geography, end user, and distribution channel.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Medical Devices

North America Neurology Devices Market Analysis

The North America Neurology Devices Market size was valued at $6.31 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.80% from 2022 to 2030 and will reach $10.68 Bn in 2030. The main factors driving the growth of the global neurology devices market are the rise in the elderly population around the world, the increased demand for minimally invasive procedures, and the rise in disposable income. The market is segmented by product type and by the end user. The key players in the North America neurology device market are Abbott Laboratories, Boston Scientific, Medtronic, Stryker, and B. Braun SE.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Healthcare Services

North America Home Healthcare Market Analysis

The North America home healthcare market was valued at $1,013 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.6% from 2022 to 2030 and will reach $1,689 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by component and product. Some key players in this market are lmost Farally, Amedisys Inc., Kindred Healthcare, Koninklijke Philips N.V. (U.S.A), Davita Inc. (U.S.A), Cardinal Health (U.S.A), Sunrise Medical (U.S.A), General Electric compaG.E. (C.f.)

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Healthcare Services

North America Palliative Care Market Analysis

The North America Palliative care market is projected to grow from $6.54 Bn in 2022 to $11.24 Bn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The main factors driving the growth would be the increasing prevalence of chronic diseases, government initiatives, well-established reimbursement policies, and extensive studies and research relating to the palliative care market. The market is segmented by service type and by the end user. Some of the major players include Amedisys, Vitas Healthcare, Golden Living Centers, Genesis Healthcare, Home Instead, and Kindred hospice.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Healthcare Services

North America Cancer Pain Management Market Analysis

The North America Cancer Pain Management market is projected to grow from $3.26 Bn in 2022 to $4.57 Bn by 2030, registering a CAGR of 4.3% during the forecast period of 2022-2030. The main factors driving the growth would be the launch of advanced novel pain management drugs, increasing cancer incidence, and the growing need for non-invasive and minimally invasive pain management treatment. The market is segmented by drug type and by disease. Some of the major players include Collegium Pharmaceutical, Pfizer, Abbott, Sorrento Therapeutics, WEX Pharmaceuticals, and Tetra Bio-Pharma.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Digital Health

North America Electronic Health Records Market Analysis

The North America Electronic Health Record (EHR) market size was valued at $11.88 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 2% from 2022 to 2030 and will reach $13.92 Bn in 2030. This growth can be attributed to the increasing adoption of EHR in healthcare facilities. The market is segmented by product, application, and end North America. Some of the major players are Epic Systems, Allscripts, McKesson, Meditech, and others.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Feb, 2023 | PRICE: $3999

Clinical Trials

North America Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Analysis

This report presents a strategic analysis of the North America Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the North America Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market, offering unmatched value, accuracy and expert insights.

PUBLISHED: Nov, 2022 | FORMAT: PPT | LAST UPDATED: Jan, 2023 | PRICE: $3999

subscribe to our newsletter
up